1. Home
  2. STVN vs BBWI Comparison

STVN vs BBWI Comparison

Compare STVN & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • BBWI
  • Stock Information
  • Founded
  • STVN 1949
  • BBWI 1963
  • Country
  • STVN Italy
  • BBWI United States
  • Employees
  • STVN N/A
  • BBWI N/A
  • Industry
  • STVN Containers/Packaging
  • BBWI Clothing/Shoe/Accessory Stores
  • Sector
  • STVN Consumer Discretionary
  • BBWI Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • BBWI Nasdaq
  • Market Cap
  • STVN 5.7B
  • BBWI 6.1B
  • IPO Year
  • STVN 2021
  • BBWI N/A
  • Fundamental
  • Price
  • STVN $21.55
  • BBWI $29.59
  • Analyst Decision
  • STVN Buy
  • BBWI Buy
  • Analyst Count
  • STVN 6
  • BBWI 18
  • Target Price
  • STVN $25.08
  • BBWI $42.71
  • AVG Volume (30 Days)
  • STVN 334.9K
  • BBWI 6.1M
  • Earning Date
  • STVN 05-08-2025
  • BBWI 06-03-2025
  • Dividend Yield
  • STVN 0.27%
  • BBWI 2.69%
  • EPS Growth
  • STVN N/A
  • BBWI N/A
  • EPS
  • STVN 0.45
  • BBWI 3.61
  • Revenue
  • STVN $1,143,012,735.00
  • BBWI $7,307,000,000.00
  • Revenue This Year
  • STVN $8.42
  • BBWI $4.63
  • Revenue Next Year
  • STVN $10.36
  • BBWI $3.02
  • P/E Ratio
  • STVN $47.85
  • BBWI $8.19
  • Revenue Growth
  • STVN 1.72
  • BBWI N/A
  • 52 Week Low
  • STVN $16.56
  • BBWI $24.96
  • 52 Week High
  • STVN $28.77
  • BBWI $52.99
  • Technical
  • Relative Strength Index (RSI)
  • STVN 52.82
  • BBWI 50.23
  • Support Level
  • STVN $21.13
  • BBWI $28.53
  • Resistance Level
  • STVN $22.46
  • BBWI $30.80
  • Average True Range (ATR)
  • STVN 1.25
  • BBWI 1.89
  • MACD
  • STVN 0.07
  • BBWI 0.41
  • Stochastic Oscillator
  • STVN 75.56
  • BBWI 79.28

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About BBWI Bath & Body Works Inc.

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store reformatting, digital and international channels, as well as adjacent category expansions like hair and laundry.

Share on Social Networks: